Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
What Mood Symptoms may be most Difficult to Rate?
1 x
$
30.00
View Cart
Checkout
Home
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease
“What Mood Symptoms may be most Difficult to Rate?” has been added to your cart.
View cart
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease
$
30.00
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 2 Articles
Tags:
adas-cognitive-subsection-adas-cog
,
alzheimers-disease
,
alzheimers-disease-assessment-scale-adas
,
cognitive-dysfunction
,
consortium-to-establish-a-registry-for-alzheimers-disease-cerad
,
huixing-yuan
,
k-ranga-rama-krishnan
,
keith-m-gregg
,
matthias-c-kurth
,
medworks-media
,
mini-mental-status-exam-mmse
,
psychopharmacology-bulletin
,
thomas-e-gillen
Description
Description
Thomas E. Gillen, MD, MS
GENERAL PSYCHOPHARMACOLOGY
Clinical Trials in Alzheimer’s Disease
Thomas E. Gillen,MD, MS, Keith M. Gregg, PhD, Huixing Yuan, PhD, Matthias C. Kurth, MD, PhD, and K. Ranga Krishnan, MB, ChB
Related products
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Antipsychotics Case Study by Yuan-Hwa Chou
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Page load link
Go to Top
